OakChart

Aveanna Healthcare Holdings Inc

AVAHHealthcare·Medical Care Facilities·USA·Mid·NASD·Nov 11 • 1:15 PM ET

13.15-0.04 (-0.34%)
2026-11-11 19:16 CET
Market cap
2,879.26 USD m
Revenue, TTM
2,602.82 USD m
Net income, TTM
274.76 USD m
Free cash flow, TTM
155.88 USD m
EPS diluted, TTM
1.23
P/E
10.69
Compare

Price

AVAH against its 20, 50 and 200-day averages
2050200beatearnings
6.008.0010.0012.0014.005.1M10.1MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AVAHclose 13.1520-day 13.1250-day 13.08200-day 9.4113.1552w high

10.6% under the 52-week high of 14.71 on 16 Sep 2026. 52-week low 5.93 on 19 Mar 2026. Last 15 sessions, 16.1% high to low

Profile

AVAH
52-week range, 82% of the way up
5.9314.71

Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. It operates through the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing services. The HHH segment provides home health, hospice, and program services to predominately elderly populations. The MS segment offers supplies to patients requiring enteral nutrition services or respiratory care. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.

IndexRUT
Employees35500
IPOApr 29, 2021
Beta2.01
ATR, 14d0.51
Rel volume0.26
Short float6.27%
Insider own47.01%
Inst own43.07%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.87B
Enterprise Value4.28B
Income274.76M
Sales2.60B
Book/sh1.32
Cash/sh0.45
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees35500
IPOApr 29, 2021

Ratios

P/E10.69
Forward P/E14.49
PEG0.77
P/S1.10
P/B9.98
P/C29.52
P/FCF18.41
EV/EBITDA13.12
EV/Sales1.64
Quick Ratio1.16
Current Ratio1.16
Debt/Eq5.24
LT Debt/Eq4.56
Option/ShortYes / Yes

Earnings

EPS (ttm)1.23
EPS next Y0.91
EPS next Q0.21
EPS this Y37.41%
EPS next Y10.04%
EPS next 5Y18.75%
EPS past 3/5Y- -
Sales past 3/5Y10.82% 10.23%
EPS Y/Y TTM1337.90%
Sales Y/Y TTM19.52%
EPS Q/Q39.56%
Sales Q/Q13.73%
EarningsNov 12 BMO
EPS/Sales Surpr.30.72% 4.99%

Ownership

Insider Own47.01%
Insider Trans-43.77%
Inst Own43.07%
Inst Trans5.09%
ROA14.17%
ROE199.62%
ROIC17.20%
Gross Margin31.84%
Oper. Margin11.39%
Profit Margin10.56%
SMA200.23%
SMA500.46%
SMA20039.75%
Trades-

Technical

Shs Outstand218.15M
Shs Float115.68M
Short Float6.27%
Short Ratio2.34
Short Interest7.26M
52W High14.71 -10.64%
52W Low5.93 121.67%
Volatility5.28% 3.72%
ATR (14)0.51
RSI (14)51.27
Beta2.01
Rel Volume0.26
Avg Volume3.10M
Volume473,570

Performance

Perf Week-7.62%
Perf Month7.92%
Perf Quarter16.43%
Perf Half Y94.17%
Perf YTD60.89%
Perf Year46.38%
Perf 3Y721.56%
Perf 5Y52.32%
Perf 10Y-
Recom1.64
Target Price15.05
Prev Close13.19
Price13.15
Change %-0.34%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jun 03, 2026UpgradeRRBC Capital MktsSector Perform → Outperform$10-23.9%
May 15, 2026UpgradeSStephensEqual-Weight → Overweight$11-16.3%
Mar 20, 2026UpgradeRRaymond JamesOutperform → Strong Buy$13-1.1%
Dec 08, 2025InitiatedWWilliam BlairOutperform
Nov 13, 2025InitiatedBBMO Capital MarketsOutperform$11-16.3%
Sep 18, 2025UpgradeJJP MorganUnderweight → Neutral$10-23.9%
Aug 19, 2025UpgradeUUBSSell → Neutral$8-39.1%
Aug 19, 2025UpgradeBBarclaysEqual Weight → Overweight$9.50-27.7%
Jul 21, 2025UpgradeJJefferiesHold → Buy$6-54.4%
Jul 02, 2025InitiatedBBarclaysEqual Weight$5.50-58.2%

Peers

Mkt cap
TickerCompanyMkt cap
ADUSAddus HomeCare Corp2.32B
PNTGPennant Group Inc1.29B
MDPediatrix Medical Group Inc2.40B
BTSGBrightSpring Health Services Inc14.55B
CHEChemed Corp7.10B
NHCNational Healthcare Corp3.30B
AMNAMN Healthcare Services Inc1.47B
ENSGEnsign Group Inc10.77B
OPCHOption Care Health Inc4.74B
INNVInnovAge Holding Corp1.27B

Insider trading

latest 14 of 71
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ERICA G SCHWARTZDirectorSep 09 '26Proposed Sale14.0046,071644,994Sep 09 04:47 PM
ERICA G SCHWARTZDirectorAug 27 '26Proposed Sale14.00230,3433,224,802Aug 27 05:48 PM
J.H. Whitney Equity Partners V10% OwnerAug 20 '26Sale11.5012,496,077143,704,8860Aug 24 06:26 PM
J.H. Whitney Equity Partners V10% OwnerAug 21 '26Sale11.502,250,00025,875,00012,315,892Aug 24 06:26 PM
WILLIAMS ROBERT M JR10% OwnerAug 20 '26Sale11.5014,500,002166,750,0230Aug 24 06:25 PM
WILLIAMS ROBERT M JR10% OwnerAug 21 '26Sale11.502,250,00025,875,00012,315,892Aug 24 06:25 PM
VIGANO PAUL R10% OwnerAug 20 '26Sale11.5014,500,002166,750,0230Aug 24 06:16 PM
VIGANO PAUL R10% OwnerAug 21 '26Sale11.502,250,00025,875,00012,315,892Aug 24 06:16 PM
Windley Rodney DDirectorAug 20 '26Sale11.50180,0002,070,0002,078,017Aug 24 04:30 PM
Shaner JeffChief Executive OfficerAug 20 '26Sale11.5090,0001,035,0002,561,972Aug 24 04:30 PM
Reisz Edwin C.Chief Administrative OfficerAug 20 '26Sale11.5050,000575,0001,397,897Aug 24 04:30 PM
WILLIAMS ROBERT M JR10% OwnerJun 30 '26Sale8.013,000,00024,030,000190,130Jul 02 12:18 PM
VIGANO PAUL R10% OwnerJun 30 '26Sale8.013,000,00024,030,000190,130Jul 02 12:13 PM
J.H. Whitney Equity Partners V10% OwnerJun 30 '26Sale8.012,419,03519,376,47010,112,123Jul 02 12:09 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
FESMFidelity Enhanced Small Cap Core ETFAUM: 6.82B
DFASU.S. Small Cap Portfolio-ETF Class Shares-
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
DFMCU.S. Micro Cap Portfolio ETF Class Shares-
DFACU.S. Core Equity 2 Portfolio-ETF Class Shares-
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 198

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-12-0.207--679.4810
2026Q22026-08-130.2200.1680.180670.48638.6110
2026Q12026-05-140.1800.1250.188647.92613.2210
2025Q42026-03-190.1700.1540.800662.48643.0310
2025Q32025-11-060.1500.1020.063621.94588.688
2025Q22025-08-070.1800.0360.128589.55535.378
2025Q12025-05-080.100-0.0030.025559.22513.086
2024Q42025-03-130.0500.0010.143519.87505.435
2024Q32024-11-070.020-0.013-0.222509.02495.878
2024Q22024-08-080.010-0.0210.071504.96493.498
2024Q12024-05-09-0.030-0.050-0.058490.65483.987
2023Q42024-03-14-0.020-0.025-0.135478.84464.997
2023Q32023-11-09-0.030-0.022-0.541478.01453.697
2023Q22023-08-10-0.020-0.0370.135471.95457.578
2023Q12023-05-11-0.050-0.060-0.169466.41452.038
2022Q42023-03-16-0.030-0.021-1.277451.15448.169

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY0.258--0.3071,488-
2021FY0.4200.419-0.6341,6791,682
2022FY0.0000.018-3.5681,7881,785
2023FY-0.110-0.116-0.7081,8951,881
2024FY0.0600.012-0.0572,0252,008
2025FY0.6000.5801.0502,4332,416
2026FY-0.825--2,693
2027FY-0.907--2,900
2028FY-1.005--3,067

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-031010679.48669.43691.7
2026Q3S2026-10-271020679.48669.43691.7
2026Q3S2026-10-231060679.48669.43691.7
2026Q3S2026-09-221060679.51669.43691.7
2026Q3S2026-09-151070679.51669.43691.7
2026Q3S2026-09-101080679.51669.43691.7
2026Q3S2026-08-231070677.81667691.7
2026Q3S2026-08-211080677.81667691.7
2026Q3S2026-08-201080677.81667691.7
2026Q3S2026-08-191070675.56667687.54
2026Q3S2026-08-161080675.56667687.54
2026Q3S2026-08-1310100675.56667687.54
2026Q3S2026-07-131061663.19641.75675.7
2026Q3S2026-07-091061663.16641.75675.7

Estimate history

EPS, annual-0.254-0.412-0.307-0.634-3.568-0.708-0.0571.0471.2297
Period20182019202020212022202320242025TTM
EPS, quarterly0.071-0.2220.1430.0250.1280.0630.80.1880.179
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual1253.6731384.0651495.1051678.6181787.6451895.2092024.5062433.1992602.82
Period20182019202020212022202320242025TTM
Sales, quarterly504.958509.023519.872559.224589.553621.942662.48647.915670.483
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual185.9185.9185.9184.732188.859190.733193.225210.996218.153
Period20182019202020212022202320242025MRQ
Shares, quarterly192.484193.225193.225195.094208.259208.911210.996217.51218.153
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,602.822,433.202,024.511,895.211,787.641,678.621,495.111,384.071,253.67
Cost of Goods Sold Incl. D&A1,773.961,633.261,399.741,313.561,255.731,141.061,057.62979.13871.29
Gross Profit828.86799.94624.76581.65531.91537.55437.49404.93382.38
Selling, General and Administrative Excl. Other530.70530.50468.62473.30449.12405.49336.72319.85301.04
Other Operating Expense1.691.865.27-6.033.65-0.34-0.091.224.43
Operating Income296.47267.59150.87114.3879.15132.40100.8583.8676.91
Interest Expense124.68140.09156.60153.25107.7268.9382.9892.3075.54
Unusual Expense41.7046.6426.28134.58636.05169.02107.8060.8148.21
Net Income Before Taxes154.11106.955.07-139.00-663.81-113.58-51.73-75.03-49.66
Income Taxes-120.65-118.0916.00-4.47-1.783.475.321.49-2.51
Consolidated Net Income274.76225.03-10.93-134.52-662.03-117.04-57.05-76.52-47.15
Net Income From Continuing Operations274.76225.03-10.93-134.52-662.03-117.04-57.05-76.52-47.15
Net Income274.76225.03-10.93-134.52-662.03-117.04-57.05-76.52-47.15
EPS (Recurring)1.351.200.04-0.21-1.170.010.10-0.18-0.07
EPS (Basic, Before Extraordinaries)1.301.11-0.06-0.71-3.57-0.63-0.31-0.41-0.25
EPS (Diluted)1.231.05-0.06-0.71-3.57-0.63-0.31-0.41-0.25
EBITDA325.96295.81182.03144.48117.96167.79131.08110.8788.85
Non-Operating Income (Expense)24.0226.0837.0834.450.81-8.03-1.16-5.78-2.82
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense24.6125.4210.428.1512.569.901.381.421.55
Price To Earnings Ratio10.7310.73-------
Price To Sales Ratio0.790.710.440.270.080.81---
Gross Margin31.8432.8830.8630.6929.7632.0229.2629.2630.50
Operating Margin11.3911.007.456.044.437.896.756.066.14
Net Margin10.569.25-0.54-7.10-37.03-6.97-3.82-5.53-3.76
Shares Outstanding218.15211.00193.23190.73188.86184.73185.90185.90185.90
Market Capitalization2,879.262,879.26883.04511.16145.021,362.811,324.14--

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue670.48647.91662.48621.94589.55559.22519.87509.02
Cost of Goods Sold Incl. D&A454.81445.53451.91421.72381.37378.26350.60351.91
Gross Profit215.68202.38210.57200.22208.18180.96169.28157.11
Selling, General and Administrative Excl. Other128.55126.44132.17143.53127.62127.17120.84117.16
Other Operating Expense0.140.001.130.420.150.170.002.86
Operating Income86.9875.9477.2756.2780.4153.6348.4437.10
Interest Expense27.7829.1632.6235.1336.0036.3438.1039.24
Unusual Expense7.587.2612.1514.716.3513.43-9.0135.07
Net Income Before Taxes56.4744.9839.2413.4244.1410.1526.93-27.33
Income Taxes16.183.32-139.51-0.6517.114.96-2.2515.51
Consolidated Net Income40.2941.65178.7514.0627.025.1929.18-42.84
Net Income From Continuing Operations40.2941.65178.7514.0627.025.1929.18-42.84
Net Income40.2941.65178.7514.0627.025.1929.18-42.84
EPS (Recurring)0.200.210.840.110.150.070.11-0.09
EPS (Basic, Before Extraordinaries)0.180.190.850.070.130.030.15-0.22
EPS (Diluted)0.180.190.800.060.130.030.14-0.22
EBITDA94.5283.5984.4663.4087.3860.5855.6444.45
Non-Operating Income (Expense)4.855.456.746.986.086.287.599.89
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.2714.313.123.924.085.882.932.87
Price To Earnings Ratio10.736.3322.69117.95300.57---
Price To Sales Ratio0.790.560.740.850.490.530.470.50
Gross Margin32.1731.2431.7932.1935.3132.3632.5630.87
Operating Margin12.9711.7211.669.0513.649.599.327.29
Net Margin6.016.4326.982.264.580.935.61-8.42
Shares Outstanding218.15217.51211.00208.91208.26195.09193.23193.23
Market Capitalization2,879.261,400.761,706.801,852.911,020.341,057.41883.041,004.77

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments193.2684.2943.9419.2230.49137.343.338.00
Short Term Receivables316.12277.66245.81225.63225.29180.88164.30190.61
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets50.8630.7225.1424.9023.4322.4218.7216.32
Total Current Assets560.23392.67314.89269.75279.21340.64186.34214.93
Net Property, Plant & Equipment55.6958.6570.0577.3583.3778.8780.4727.25
Total Investments and Advances8.7038.2053.5081.800.000.000.100.00
Long-Term Note Receivable28.8122.4321.3222.8625.5323.9925.1521.74
Intangible Assets1,213.601,144.121,148.561,255.551,938.431,389.961,280.361,278.76
Deferred Tax Assets150.4817.1724.1855.8946.032.93--
Other Assets8.217.334.674.447.837.635.098.27
Total Assets2,025.721,680.571,637.161,767.652,380.401,844.021,577.521,550.94
Short Term Debt Incl. Current Port. of LT Debt200.44198.60183.04169.15147.8425.2721.669.40
Accounts Payable31.9736.4430.1344.6252.620.000.000.00
Other Current Liabilities192.04167.13141.59112.73144.36235.15146.88188.95
Total Current Liabilities424.46402.17354.76326.50344.83260.41168.54198.36
Long Term Debt1,314.071,303.371,316.161,326.901,271.901,205.241,060.78943.03
Provision for Risks Charges77.8766.9361.6058.3460.6554.3351.4143.70
Deferred Tax Liabilities13.3423.0729.0459.7349.0827.410.831.75
Other Liabilities0.807.123.040.3615.9929.4625.0219.11
Total Liabilities1,830.531,802.651,764.601,771.821,742.451,576.851,306.581,205.95
Non-Equity Reserves0.731.462.132.132.132.130.750.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity194.46-123.55-129.57-6.31635.82265.03270.19344.99
Total Shareholders Equity194.46-123.55-129.57-6.31635.82265.03270.19344.99
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity194.46-123.55-129.57-6.31635.82265.03270.19344.99
Total Liabilities & Stockholders Equity2,025.721,680.571,637.161,767.652,380.401,844.021,577.521,550.94
Book Value Per Share0.92-0.64-0.68-0.033.441.431.451.86
Tangible Book Value Per Share-4.83-6.56-6.70-6.68-7.05-6.05-5.43-5.02
Full-Time Employees35,50033,50033,50033,70033,00042,00032,000-
Price to Book Ratio10.02-5.64-4.840.642.151.76--
Return on Assets12.14-0.66-7.90-31.92-5.54-3.33-4.89-
Return on Equity634.70---210.33-25.99-21.32-24.88-
Return on Invested Capital14.92-0.93-11.34-50.13-6.14-3.88-5.75-3.66
Quick Ratio1.320.980.890.830.811.311.111.08
Current Ratio1.320.980.890.830.811.311.111.08

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income274.76225.03-10.93-134.52-662.03-117.04-57.05-76.52-47.15
Depreciation29.5028.2231.1630.1038.8235.3930.2227.0111.94
Other Funds (Non Cash)39.9664.6739.14149.48617.15140.3293.3328.6525.68
Funds from Operations200.58174.8960.4146.07-6.1859.9860.08-21.77-13.16
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-34.89-52.66-29.97-23.40-42.22-71.3356.5413.0634.76
Cash from Operating Activities165.69122.2430.4522.67-48.40-11.35116.62-8.7121.60
Capital Expenditures-9.81-7.45-6.32-6.12-12.01-15.95-15.24-16.64-19.58
Net Assets From Acquisitions-169.44-14.850.000.00-2.01-666.91-178.31-1.19-209.97
Sale of Fixed Assets and Businesses0.000.000.000.000.460.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses-4.630.000.00-2.68-11.72-0.850.000.000.00
Other Sources0.000.000.000.000.001.890.000.000.00
Cash from Investing Activities-183.89-22.30-6.32-8.79-25.29-681.83-193.54-17.82-229.55
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock7.806.523.090.944.01475.5147.890.0054.42
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock7.806.523.090.944.01475.5147.890.0054.42
Proceedsfrom Stock Options0.000.000.000.004.01474.5447.890.0054.42
Issuance or Reduction of Debt, Net-3.35-3.76-2.36-5.7339.9326.36133.6167.46149.73
Change in Long Term Debt0.40-0.01-16.11-20.7339.9326.36133.6167.46149.73
Issuance of Long Term Debt1,317.741,317.740.0018.9574.481,309.30191.57658.53171.49
Reduction of Long Term Debt-1,317.34-1,317.75-16.11-39.68-34.55-1,282.94-57.96-591.07-21.76
Net Financing Active Other Cash Flow10.216.2715.4915.6318.4784.4629.44-45.600.00
Other Financing Activities Uses-0.48-6.290.000.00-21.53-68.000.00-45.600.00
Cash from Financing Activities14.669.0316.2210.8562.42586.33210.9421.86204.15
Net Change in Cash-3.54108.9740.3524.73-11.27-106.86---
Free Cash Flow155.88114.7924.1316.56-60.41-27.30101.38-25.352.02
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow13.1315.1337.2630.75-----
Deferred Taxes & Investment Tax Credit--143.031.031.01-0.121.31-6.42-0.92-3.63

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments97.20189.27193.26145.87100.7471.49
Short Term Receivables340.99335.60316.12317.49320.64305.34
Inventories0.000.000.000.000.000.00
Other Current Assets39.9150.4350.8639.2528.5430.79
Total Current Assets478.09575.30560.23502.60449.92407.62
Net Property, Plant & Equipment56.8853.8655.6955.2556.5357.50
Total Investments and Advances12.008.008.7014.6020.7026.70
Intangible Assets1,375.841,212.971,213.601,210.241,213.181,143.77
Deferred Tax Assets136.76137.14150.48---
Other Assets8.464.358.215.669.556.67
Total Assets2,106.382,022.052,025.721,810.461,770.971,660.74
Short Term Debt Incl. Current Port. of LT Debt194.69193.70200.44194.16194.03193.23
Accounts Payable32.4134.3631.9727.0946.5930.49
Other Current Liabilities184.22162.38192.04188.44173.61164.59
Total Current Liabilities411.32390.43424.46409.69414.23388.31
Long Term Debt1,310.601,308.601,314.071,315.901,297.211,299.39
Provision for Risks Charges96.4582.2477.8767.6663.4864.41
Deferred Tax Liabilities--13.346.506.506.51
Other Liabilities0.000.000.800.800.800.80
Total Liabilities1,818.371,781.271,830.531,800.541,782.231,759.41
Non-Equity Reserves0.730.730.730.730.731.46
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity287.28240.05194.469.18-11.99-100.13
Total Shareholders Equity287.28240.05194.469.18-11.99-100.13
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity287.28240.05194.469.18-11.99-100.13
Total Liabilities & Stockholders Equity2,106.382,022.052,025.721,810.461,770.971,660.74
Book Value Per Share1.321.100.920.04-0.06-0.51
Tangible Book Value Per Share-4.99-4.47-4.83-5.75-5.88-6.38
Full-Time Employees--35,500---
Price to Book Ratio10.026.99185.85-154.05-10.19-8.48
Return on Assets14.1714.2012.144.371.080.33
Return on Equity199.62373.77634.70---
Return on Invested Capital2.522.6911.851.062.100.43
Quick Ratio1.161.471.321.231.091.05
Current Ratio1.161.471.321.231.091.05

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income40.2941.65178.7514.0627.025.19
Depreciation7.547.657.187.136.976.95
Other Funds (Non Cash)5.845.7412.0216.3611.8824.41
Funds from Operations53.6755.0454.3137.5545.8737.16
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital27.25-50.69-4.59-6.864.59-45.79
Cash from Operating Activities80.934.3549.7230.6950.45-8.63
Capital Expenditures-1.29-4.56-1.95-2.02-1.13-2.35
Net Assets From Acquisitions-169.440.000.000.00-14.850.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses-4.630.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-175.37-4.56-1.95-2.02-15.98-2.35
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock2.800.272.582.150.001.79
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock2.800.272.582.150.001.79
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-2.56-5.72-6.3511.27-3.62-5.06
Change in Long Term Debt-2.56-5.72-6.3515.02-3.62-5.06
Issuance of Long Term Debt0.000.000.001,317.740.000.00
Reduction of Long Term Debt-2.56-5.72-6.35-1,302.72-3.62-5.06
Net Financing Active Other Cash Flow2.121.673.393.03-1.611.46
Other Financing Activities Uses0.00-0.480.000.00-4.62-1.68
Cash from Financing Activities2.36-3.78-0.3816.45-5.23-1.81
Net Change in Cash-92.08-3.9947.3945.1329.24-12.79
Free Cash Flow79.64-0.2147.7728.6849.33-10.98
Price to Free Cash Flow13.1311.2915.7325.3514.0541.91

Revenue breakdown

United States2024: 2.02B 2025: 2.43B
Home Health And Hospice2024: 217.81M 2025: 248.56M
Medical Solutions2024: 172.09M 2025: 183.50M
Private Duty Services2024: 1.63B 2025: 2.00B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.27%7.3M115.7M3.02M
2026-10-154.61%5.3M115.7M3.04M
2026-09-304.88%5.7M116.1M2.99M
2026-09-154.74%5.5M116.1M2.86M
2026-08-314.74%5.5M115.8M2.68M
2026-08-145.35%5.3M99.9M2.29M
2026-07-314.43%4.4M99.7M2.04M
2026-07-154.69%4.5M96.4M1.91M
2026-06-304.00%3.9M96.4M1.72M
2026-06-154.02%3.6M89.1M1.51M
2026-05-294.45%4.1M92.8M1.37M
2026-05-154.85%4.0M83.1M1.38M
2026-04-303.70%2.9M78.9M1.19M
2026-04-154.72%3.7M78.9M1.18M
2026-03-315.71%4.2M73.2M1.25M
2026-03-136.13%4.5M73.2M1.20M
2026-02-275.84%4.1M70.3M1.18M
2026-02-136.41%4.5M70.3M1.12M
2026-01-306.60%4.6M69.2M1.22M
2026-01-156.57%4.5M69.2M1.38M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.509.2011.600.0012.5860.000.000.990-0.0170.001
call5.006.709.100.007.3480.000.000.983-0.0170.001
call7.505.106.600.004.7980.000.000.972-0.0160.001
call10.002.004.003.422.8672.000.000.924-0.0230.003
call12.501.301.451.541.4243,8440.000.636-0.0610.008
call15.000.400.500.501.3715,35047.000.308-0.0560.007
call17.500.100.250.251.61738.008.000.159-0.0450.005
call20.000.000.750.002.0870.000.000.132-0.0520.004
call22.500.000.750.002.4590.000.000.117-0.0560.004
call25.000.000.750.002.8010.000.000.107-0.0600.004
put2.500.000.050.005.5480.000.00-0.009-0.0160.001
put5.000.000.050.003.7840.000.00-0.027-0.0270.001
put7.500.000.050.002.3580.000.00-0.043-0.0250.002
put10.000.050.100.101.3167.000.00-0.076-0.0210.003
put12.500.600.800.701.37569.0034.00-0.364-0.0590.008
put15.002.002.602.001.72314.002.00-0.692-0.0540.007
put17.502.604.800.002.0020.000.00-0.841-0.0430.005
put20.005.407.006.891.8902.000.00-0.868-0.0490.004
put22.507.509.900.003.1260.000.00-0.883-0.0540.004
put25.0010.0012.900.004.3000.000.00-0.893-0.0570.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13G/ASEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-028-KCurrent report2026-10-01SEC
2026-09-09144Filing for proposed sale of securities under Rule 144.SEC
2026-08-27144Filing for proposed sale of securities under Rule 144.SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-244Statement of changes in beneficial ownership of securities2026-08-20SEC
2026-08-248-KCurrent report2026-08-24SEC
2026-08-24424B4SEC
2026-08-20424B4SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-07-04SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-138-KCurrent report2026-08-13SEC
2026-08-078-KCurrent report2026-08-05SEC
2026-08-03SCHEDULE 13G/ASEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-30144Filing for proposed sale of securities under Rule 144.SEC
2026-06-30144Filing for proposed sale of securities under Rule 144.SEC
2026-06-30144Filing for proposed sale of securities under Rule 144.SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-264Statement of changes in beneficial ownership of securities2026-06-24SEC
2026-06-24144Filing for proposed sale of securities under Rule 144.SEC
2026-06-24144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800558.51M9
2026-070000
2026-0600214.61M9
2026-0500948.54K1
2026-040000
2026-030000
2026-02005.46M15
2026-0100703.85K5
2025-12001.40M10
2025-110000

Institutional holders

Manager% owned
BAIN CAPITAL INVESTORS LLC37.47%
J.H. Whitney Equity Partners VII, LLC12.43%
Nut Tree Capital Management, LP5.93%
FMR LLC3.57%
BlackRock, Inc.3.40%
Ophir Asset Management Pty Ltd2.34%
VANGUARD CAPITAL MANAGEMENT LLC1.69%
DIMENSIONAL FUND ADVISORS LP1.61%
BRAIDWELL LP1.41%
Boston Partners1.39%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.25%
iShares Russell 2000 ETF0.94%
Fidelity Enhanced Small Cap Core ETF0.58%
John Hancock Global Senior Loan ETF0.43%
Fidelity Small Cap Index Fund0.39%
Nuveen Quant Small Cap Equity Fund0.39%
VANGUARD EXTENDED MARKET INDEX FUND0.38%
First Trust Small Cap Growth AlphaDEX Fund0.38%
First Eagle Small Cap Opportunity Fund0.31%
Columbia Small Cap Value and Inflection Fund0.30%

OakChart. AVAH. Cached 15 minutes.